Yesterday and today has shown momentum has come back into the market and will likely continue for a few months. We have been in a no follow through market the last 2 months and now the cycle seems to have finally made the shift. This means the chances of SINT really making a substantial run after Pr is great. along with other beaten up stocks that have had good...
O2TODAY Announces Agreement to Develop Antimicrobial Face Masks with SINTX Technologies, Inc. to Help Prevent Spread of COVID-19 and Other Viral Diseases. O2TODAY and SINTX Technologies intend to capitalize on recent and promising data demonstrating the potential of SINTX’s silicon nitride powder to inactivate the SARS-CoV-2 virus that is responsible for the...
SINT not only formed its first ever Golden Cross (which is a very bullish technical formation), but also closed the first 1D candle above the 1D MA200 (orange trend-line) since November 2017. This is a very bullish long-term mix for the stock and if the 3.25 Resistance breaks we are ready to buy and triple our investment at 10.00. ** If you like our free...
SINTX Technologies, Inc. operates as a commercial biomaterial company. It focuses on using silicon nitride technology platform to develop, manufacture and sell a range of medical devices. The firm markets spinal fusion products and develops products for use in total hip and knee joint replacements. Its FDA-cleared and CE-marked spine products are marketed in...
SINTX Technologies Announces Pricing of $5.6 Million Registered Direct Offering Priced At-The-Market finance.yahoo.com SINTX TECHNOLOGIES ANNOUNCES PUBLICATION OF STUDY TO REDUCE THE SPREAD AND TRANSFER OF CORONAVIRUS today announced positive testing results demonstrating the anti-viral properties of its silicon nitride which may be useful in the reduction of...
SiNtx's stock skyrockets after upbeat data on its silicon nitride powder's effect on COVID-19 virus SARS-CoV-2 virus which causes COVID-19 was "inactivated" when exposed to its sintered silicon nitride powder in a controlled laboratory study. The company said it will share additional data soon, once the findings are published. SiNtx said it was conducting...
Is this the week SINT finally moves? Watching closely
SINTX Technologies, Inc. operates as a commercial biomaterial company. It focuses on using silicon nitride technology platform to develop, manufacture and sell a range of medical devices. The firm markets spinal fusion products and develops products for use in total hip and knee joint replacements. Its FDA-cleared and CE-marked spine products are marketed in the...
It has all the requirments to make the impossible possible... its an idea just to make some money not for holding for a long time.. when it goes near to 1.4 is time to partially sell ...
SINTX Technologies, Inc. operates as a commercial biomaterial company. It focuses on using silicon nitride technology platform to develop, manufacture and sell a range of medical devices. The firm markets spinal fusion products and develops products for use in total hip and knee joint replacements. Its FDA-cleared and CE-marked spine products are marketed in the...